维普中文期刊产品整合服务
103篇 您的检索式:作者名="Cools M J"
    题名 作者 年代 出处 被引量
1A nonmosaic 45,X karyotype in a mother with Turner's syndrome and in her daughter显示文摘COOLS M ROOMAN R P WAUTERS J 2004Fertil Steril2004,82,4:1
2Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis显示文摘Levine RL Wadleigh M Cools J 2005Cancer Cell2005,7,4:1
3Activating Mutation in the Tyrosine Kinase JAK2 in Polycythemia Vera, Essential Thrombocythemia,and Myeloid Metaplasia with MycloSibrosis 显示文摘Levine R L Wadleigh M Cools J 2005Cancer Cell2005,7,4:1
4Activating mutation in the tyrosine kinase JAN2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis显示文摘LEVINE R L WADLEIGH M COOLS J 2005Cancer Cell2005,7,:1
5Activating mutation in the tyrosine kinase JAK2 in polycythemia vera,essential thrombocythemia,and myeloid metaplasia with myelofibrosis显示文摘Levine RL Wadleigh M Cools J 2005Cancer Cell2005,7,4:1
6Filum terminale lipomas : imaging prevalence, natural history, and conus position显示文摘Cools M J A1-Holou WN Stetler WR 2014J Neurosurg Pediatr2014,13,5:1
7Activating mutation in the tyrosine kinase JAK2 in polycythemia vera,essential thrombocythemia,and myeloid metaplasia with myelofibrosis显示文摘Levine RL Wadleigh M Cools J 0,,4:1
8Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis 显示文摘Levine R L Wadleigh M Cools J 2005Cancer Cell2005,7,4:1
9Acti-vating mutation in the tyrosine kinase JAK2in poly-cythemia vera,essential thrombocythemia,and mye-loid metaplasia with myelofibrosis显示文摘LEVINE R L WADLEIGH M COOLS J 2005Cancer Cell2005,7,:1
10Activiting mutation in thetyrosine kinase JAK2 polycythaemia vera, essential thrombythemia, and myeloid metaplasia with myelofibrosis 显示文摘Levine RL Wadleigh M Cools J 2005Cancer Cell2005,7,4:1
11A scoliosis correction device based on memory metal显示文摘Veldhuizen A G Sanders M M Cool J C 1997Medical Engineering & Physics1997,19,:1
12Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis 显示文摘Levine RL Wadleigh M Cools J 2005Cancer Cell2005,7,4:1
13Activating mutation in the tyro- sine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelo brosis 显示文摘Levine RL Wudleigh M Cools J 2005Cancer Cell2005,7,4:1
14The freezing point method as a new means of measuring the concentration of the soil solution directly in the soil显示文摘Bouyocous C- J Mc Cool M M 1916Michigan Agricultural Experiment Station Technical Bulletin1916,24,:1
15Activating mutation in the tyrosine kinase JAK2 in polycythemia vera,essential thrombocythemia,and myeloid metaplasia with myelofibrosis显示文摘Levine RL Wadleigh M Cools J 0,,04:1
16Activatingmutation in the tyrosinekinase JAK2in polysythemia vera,es-sential thrombocythemia,and myeloid metaplasia with myelo-fibrosis显示文摘LEVINE R L WADLEIGH M COOLS J 2005Cancer Cell2005,7,:1
17Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thromboythemia, and myeloid metaplasia with myelofibrosis显示文摘l_evine RL Wadleigh M Cools J 2005Cancer Cell2005,7,4:1
18Elective high fre- quency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants 显示文摘Cools F Henderson - Smart D J Offringa M 2009Cochrane Database Syst Rev2009,,00:1
19Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and mye- loid metaplasia with myelofibrosis显示文摘Levine R Wadleigh M Cools J 2005Cancer Cell2005,7,4:1
20Thalidomide for the treatment of relapsed and refractory multiple myeloma 显示文摘COOL R M HERRINRTON J D 2002Pharmacotherapy2002,22,8:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费